Marc provides cutting edge strategic and regulatory advice to life sciences clients and represents them in litigation.

Marc is the Co-Head of our International Life Sciences and Healthcare group and head of our Regulatory, Public and Administrative Law Group in Brussels.

Specialising in life sciences, he provides both contentious and non-contentious strategic advice to Belgian and international pharmaceutical, biotech and medical devices companies as well as national and European industry associations facing complex regulatory frameworks. Marc's areas of expertise cover issues relating to life-cycle management, clinical trials and data, data exclusivity, marketing, energy and utilities, price and reimbursement authorisations, e-health together with distribution and advertising issues. He advises numerous biotech companies on a wide range of issues regarding Advanced Therapy Medicinal Products as well as the legal and bioethical issues relating to research and/or the use of human cells and tissues.

His public and administrative law expertise covers a full range of sub practices as public procurement and related litigation, environmental law, REACH, RoHS, WEES and other Belgian and EU regulatory compliance issues. He advises companies, public bodies and industry associations on related matters.

Marc holds a law degree from the Vrije Universiteit Brussel (VUB) where he worked for four years as a research assistant, and a degree in public and administrative law from the University of Brussels (ULB).  Before joining us, Marc was an expert adviser to the Vice-Prime Minister of Belgium for three years.

Marc regularly publishes and speaks on life sciences regulatory topics and provides an introduction to Biotech Law at the VUB. He is also member of the Board of the Belgian Biotech sector organisation BIO.BE.

News & Events

There are no forthcoming events for this area. Please click on the button below to view past events.

Talk to an expert
Find a contact

Not sure who to contact


Lawyer Testimonials
  1. "Marc Martens heads a group, who has strong expertise in the use of biological material for therapeutic applications and scientific research."

    Legal 500 EMEA, 2018
  2. Regulatory specialist Marc Martens co-heads Bird & Bird's international life sciences group. He has a specific focus on medicinal products and medical devices, with particular experience in questions concerning advanced therapies, clinical trials and data exclusivity.

    Chambers Europe 2017
  3. Marc Martens heads the healthcare and life sciences group, which advises biotech, medical devices and pharmaceuticals manufacturers, as well as industry associations.

    Legal 500 2017